Compare MGA & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGA | PEN |
|---|---|---|
| Founded | 1957 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 12.9B |
| IPO Year | 1995 | 2015 |
| Metric | MGA | PEN |
|---|---|---|
| Price | $62.17 | $329.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 17 |
| Target Price | $59.13 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 1.4M | 499.3K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $4.30 | $14.34 |
| Revenue Next Year | $2.36 | $13.71 |
| P/E Ratio | ★ $22.81 | $73.54 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $32.55 | $221.26 |
| 52 Week High | $69.94 | $362.41 |
| Indicator | MGA | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.95 | 39.29 |
| Support Level | $44.53 | $326.58 |
| Resistance Level | $69.94 | $338.99 |
| Average True Range (ATR) | 1.58 | 2.12 |
| MACD | 0.70 | 0.26 |
| Stochastic Oscillator | 99.43 | 27.52 |
Magna International prides itself on an entrepreneurial culture and a corporate constitution that outlines the distribution of profits to various stakeholders. This automotive supplier's product groups include exteriors, interiors, seating, roof systems, body and chassis, powertrain, vision and electronic systems, closure systems, electric vehicle systems, tooling and engineering, and contract vehicle assembly. In 2025, 48.6% of Magna's USD 42 billion of revenue came from North America, while Europe accounted for approximately 38% and Asia the remainder. The firm's top six customers constituted 75.9% of revenue, with the top three being GM, Mercedes, and Ford. GM was the largest contributor at 15.6%. Magna was founded in 1957, has about 144,000 employees, and is based in Aurora, Ontario.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.